You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

long-acting β2-adrenergic agonists (LABA)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tiotropium + Olodaterol Versus Inhaled Corticosteroids +

Active, not recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium (Tio)
  • +4 more
  • Taipei, China
    National Tawain University Hospital
Jan 9, 2023

Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Brussels, Belgium
    Erasme University Hospital
Jun 23, 2023

Exacerbation Risk in Asthma

Completed
  • Asthma
  • White Plains, New York
    eMax Health
Aug 12, 2022

Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

Recruiting
  • Asthma
  • To compare in both treatment arms the percentage of patients controlled at week 52.
  • Inca, Baleares, Spain
  • +16 more
Jun 16, 2023

Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma:

Recruiting
  • Asthma
  • Mepolizumab
  • Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA)
  • Lund, Skane, Sweden
    The Lung and Allergy Clinic, Skåne University Hospital (SUS)
Jan 16, 2023

Tiotropium and Olodaterol in Comparison to LABA/ICS

Completed
Has Results
  • COPD
  • Watertown, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Tiotropium and Olodaterol in Comparison to Triple Therapy

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium and Olodaterol (Tio+Olo)
  • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
  • Andover, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Asthma Trial in Nyíregyháza (Administration via pressurized metered dose inhaler (pMDI))

Recruiting
  • Asthma
  • Administration via pressurized metered dose inhaler (pMDI)
  • Nyíregyháza, Hungary
    Simplex Kft
Mar 14, 2022

South Korea Using Medical Records to Look at Different

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Long-acting Muscarinic Antagonists (LAMA)
  • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Feb 8, 2022

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Taiwan, China
    Health Data Research Center, National Taiwan University
Jan 3, 2023

Asthma Trial in Worldwide (Rilzabrutinib, )

Recruiting
  • Asthma
  • Berazategui, Buenos Aires, Argentina
  • +24 more
Dec 29, 2022

Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)

Completed
  • Asthma
  • CHF1535 200/6 µg
  • BDP 100 µg
  • Pisa, Italy
    Cardio-Thoracic and Vascular Dept, University of Pisa
Oct 28, 2021

Cardiovascular Events in Chronic Obstructive Pulmonary Disease

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
    • Aarhus, Denmark
      Aarhus Universitets hospital Skejby
    Apr 29, 2021

    COPD Trial in Belgium, Hungary (Beclomethasone dipropionate/Formoterol Fumarate/Glycopyrronium)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Beclomethasone dipropionate/Formoterol Fumarate/Glycopyrronium
    • Aalst, Belgium
    • +7 more
    Jan 24, 2022

    COPD Greek Patients Based on Standard Clinical Practice.

    Not yet recruiting
    • Copd
    • COPD Exacerbation
      • (no location specified)
      Jun 22, 2022

      Asthma Trial in Rostock (CHF 5993 100/6/12.5 µg, CHF 1535 100/6 µg)

      Completed
      • Asthma
      • CHF 5993 100/6/12.5 µg
      • CHF 1535 100/6 µg
      • Rostock, Germany
        Chiesi Clinical Trial Site 276814
      Apr 6, 2021

      Asthma Trial in Taoyuan (Correct/recheck strategy, Usual verbal instruction)

      Recruiting
      • Asthma
      • Correct/recheck strategy
      • Usual verbal instruction
      • Taoyuan, Taiwan
        Department of Thoracic Medicine, Chang Gung Memorial Hospital
      Jan 9, 2021

      Spiolto® Respimat® Versus Triple Combination Therapy in Everyday

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist
      • Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids
      • Bad Sachsa, Germany
      • +74 more
      Nov 10, 2021

      A Retrospective rEal-life daTa Study to Assess exaceRbations and

      Completed
      • COPD
      • COPD Exacerbation
        • Thessaloniki, Greece
          Papanikolaou Hospital of Thessaloniki
        Sep 7, 2022

        Asthma Trial in United States (RPT193, Placebo)

        Recruiting
        • Asthma
        • San Jose, California
        • +5 more
        Jul 12, 2023

        Asthma Trial in London (Salmeterol Xinafoate, Salmeterol Fluticasone)

        Unknown status
        • Asthma
        • Salmeterol Xinafoate
        • Salmeterol Fluticasone
        • London, United Kingdom
          St Mary's Hospital, Imperial College Healthcare NHS Trust
        Aug 4, 2020

        COPD Trial in Miami (Bevespi, Bretzri)

        Recruiting
        • Chronic Obstructive Pulmonary Disease
        • Miami, Florida
          University of Miami
        Jan 23, 2023

        Persistent Asthma Trial in United States (Fp MDPI, FS MDPI, FLOVENT HFA)

        Completed
        Has Results
        • Persistent Asthma
        • Fp MDPI
        • +4 more
        • Birmingham, Alabama
        • +100 more
        Nov 6, 2021

        Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

        Completed
        • Asthma
        • Fluticasone with salmeterol
        • +3 more
        • Hackensack, New Jersey
        • +2 more
        Oct 12, 2022